Loading ETF research
Fetching the latest fund profile, holdings, and market data.
Loading ETF research
Fetching the latest fund profile, holdings, and market data.
NASDAQ Global MarketEquity ETF
$206.49
+$6.01 · +3.00%
At close: Oct 9, 4:00 PM ET
Regular session · ET · Market data may be delayed.
The iShares Biotechnology ETF (IBB) is designed to mirror the investment performance of a specific market index. This index comprises publicly traded stocks from companies operating within the U.S. biotechnology sector.
Fund facts updated Oct 10, 2026.
Day range
Current $206.49
52-week range
Current $206.49
1 month
+1.75%
3 months
+7.51%
Year to date
+22.35%
1 year
+36.80%
3 years
+67.02%
5 years
+33.64%
Since inception
+498.52%
Cumulative price changes exclude distributions and investor-specific taxes, trading costs, and cash flows.
Showing 15 of 244 reported holdings
Displayed portfolio weight: 59.12%
Holdings data updated Oct 10, 2026.
Sep 15, 2026
Sep 15, 2026
Sep 18, 2026
$0.0112
Quarterly
Jun 15, 2026
Jun 15, 2026
Jun 18, 2026
$0.0238
Quarterly
Mar 17, 2026
Mar 17, 2026
Mar 20, 2026
$0.1218
Quarterly
Dec 16, 2025
Dec 16, 2025
Dec 19, 2025
$0.1831
Quarterly
Sep 16, 2025
Sep 16, 2025
Sep 19, 2025
$0.0828
Semiannual
Mar 18, 2025
Mar 18, 2025
Mar 21, 2025
$0.1212
Quarterly
Dec 17, 2024
Dec 17, 2024
Dec 20, 2024
$0.0624
Quarterly
Sep 25, 2024
Sep 25, 2024
Sep 30, 2024
$0.2005
Semiannual
Mar 21, 2024
Mar 22, 2024
Mar 27, 2024
$0.126
Quarterly
Dec 20, 2023
Dec 21, 2023
Dec 27, 2023
$0.124
Quarterly
Amounts are shown per share in the ETF trading currency and adjusted for splits when the provider supplies an adjusted value; otherwise the reported amount is used.
Continue in GoAI
Connect this ETF with broader market context and continue your research in GoAI.
ETF data may be delayed, incomplete, or revised. Holdings and exposures change over time. Historical performance does not guarantee future results. This page is for informational and educational purposes only and does not constitute investment advice or a recommendation.
